课题基金 / 基金详情

The analysis of the effect of novel agent for bone metabolism on bone metastasis

The analysis of the effect of novel agent for bone metabolism on bone metastasis
新型骨代谢药物对骨转移的影响分析
批准号:
23791668
负责人:
MAEDA Kazuhiro
金额:
$2.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012

项目摘要

项目成果

MAEDA Kazuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
RANK是RANKL的受体,RANKL是破骨细胞形成所必需的分子。此前,我们曾报道Wnt5a-Ror2途径可增强巨噬细胞RANK的表达。另一方面,另一个研究小组报道,RANK在肿瘤细胞中的表达增强了骨转移。综上所述,这些发现表明,肿瘤细胞表达的Wnt以自分泌的方式影响自身,并通过诱导RANK表达促进骨转移。为了验证这一假说,我们使用与骨骼有亲和力的细胞系,如乳腺癌和前列腺癌细胞系进行实验。结果表明,与对照细胞相比,这些细胞表达RANK、WNT5a和Ror1/2。这些结果表明,肿瘤细胞表达的Wnt5a以自分泌方式作用于自身表达的Ror2,并通过诱导肿瘤细胞RANK表达来促进骨转移。
英文摘要
RANK is a receptor of RANKL which is an essential molecule for osteoclastogenesis. Previously, we reported that the Wnt5a-Ror2 pathway enhances the expression of RANK in macrophages. On the other hand, another group reported that the expression of RANK in tumor cells enhance bone metastasis. Taken together, these findings suggest that the Wnt expressed by tumor cells affects itself in an autocrine manner, and promotes bone metastasis through the induction of RANK expression.To test this hypothesis, we performed experiments using cell lines which have affinity for the bone such as breast and prostate cancer cell lines. In results these cells highly expressed RANK, Wnt5a and Ror1/2 in comparison with control cells. These results indicate that Wnt5a expressed by tumor cells act on Ror2 expressed in itself in an autocrine manner, and enhanced bone metastasis through the induction of RANK expression in tumor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/srep04493
发表时间: 2014-03-27
期刊: Scientific reports
影响因子: 4.6
作者: [Okamoto M, Udagawa N, Uehara S, Maeda K, Yamashita T, Nakamichi Y, Kato H, Saito N, Minami Y, Takahashi N, Kobayashi Y]
通讯作者: Kobayashi Y
Wnt5a-Ror2 signaling between osteoblasts and osteoclast precursors enhances osteoclastogenesis
成骨细胞和破骨细胞前体之间的 Wnt5a-Ror2 信号传导增强破骨细胞生成
DOI: --
发表时间: 2012
期刊: Nat. Med
影响因子: --
作者: [Maeda, K., Kobayashi, Y., Udagawa, N., (省略7名), Nishita, M., Marumo, K., Martin, T. J., Minami, Y., Takahashi, N.]
通讯作者: N.
骨芽細胞系細胞と破骨細胞前駆細胞間のWnt5a-Ror2シグナルは破骨細胞分化を促進する
成骨细胞谱系细胞和破骨细胞前体细胞之间的Wnt5a-Ror2信号促进破骨细胞分化
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Maeda K, Kobayashi Y, Takahashi N, Marumo K, 前田 和洋]
通讯作者: 前田 和洋
Wntによる破骨細胞の分化制御機構
Wnt调控破骨细胞分化的机制
DOI: --
发表时间: 2012
期刊: 細胞
影响因子: --
作者: [山崎真哉, 橋本祐介, 瀧上順誠, 寺井彰三郎, 中村博亮, 小林泰浩,前田和洋,上原俊介]
通讯作者: 小林泰浩,前田和洋,上原俊介
共 19 条
    Development of anti-cancer drug medication scheduling method based on the systematic understanding of biochemical networks
    • 批准号:
      24800050
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.91万
    • 财政年份:
      2012
    • 负责人:
      MAEDA Kazuhiro
    • 依托单位:
    To clarify the molecular mechanism of novel therapeutic agent which suppresses bone resorption through inhibits noncanonical Wnt signaling.
    • 批准号:
      21890261
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.62万
    • 财政年份:
      2009
    • 负责人:
      MAEDA Kazuhiro
    • 依托单位:
    海外基金